$11.58 0.00 (%) Biocryst Pharmaceuticals Inc - NASDAQ

Oct. 17, 2014 | 04:00 PM

Partner Headlines

  1. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness | Oct. 17, 2014 | 14:52PM EST
  2. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  3. Making Money With Charles Payne: 10/16/14

    FoxBusiness | Oct. 16, 2014 | 18:00PM EST
  4. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 8, 2014 | 18:00PM EST
  5. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 13:04PM EST
  6. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga | Oct. 8, 2014 | 07:19AM EST
  7. Making Money With Charles Payne: 10/07/14

    FoxBusiness | Oct. 7, 2014 | 18:00PM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 7, 2014 | 08:10AM EST
  9. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 Trial Results

    Benzinga | Oct. 7, 2014 | 07:10AM EST
  10. Making Money With Charles Payne: 10/0614

    FoxBusiness | Oct. 6, 2014 | 18:00PM EST
  11. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD | Oct. 6, 2014 | 14:31PM EST
  12. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 14:08PM EST
  13. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson

    Benzinga | Oct. 6, 2014 | 14:00PM EST
  14. Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies

    Benzinga | Oct. 6, 2014 | 10:58AM EST
  15. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD | Oct. 3, 2014 | 09:02AM EST
  16. Making Money With Charles Payne: 10/01/14

    FoxBusiness | Oct. 1, 2014 | 18:00PM EST
  17. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD | Oct. 1, 2014 | 14:20PM EST
  18. Morning Market Movers

    Benzinga | Oct. 1, 2014 | 09:39AM EST
  19. Making Money With Charles Payne: 09/30/14

    FoxBusiness | Oct. 1, 2014 | 06:18AM EST
  20. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 15:54PM EST
  21. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga | Sep. 24, 2014 | 13:17PM EST
  22. BioCryst Receives Additional NIAID Funding For Manufacture and Development Of BCX4430, $19.9M Has Been Awarded To Date Under The Contract

    Benzinga | Sep. 18, 2014 | 12:08PM EST
  23. Momentum Stocks Showing Weakness

    Benzinga | Sep. 15, 2014 | 17:33PM EST
  24. BioCryst Announces RAPIVAB Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting

    Benzinga | Sep. 6, 2014 | 11:23AM EST
  25. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety Data Unavailable

    Benzinga | Sep. 5, 2014 | 13:18PM EST
  26. BioCryst To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting

    Benzinga | Sep. 2, 2014 | 06:53AM EST
  27. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga | Aug. 29, 2014 | 07:32AM EST
  28. Biotechs That Might Benefit From Ebola

    Benzinga | Aug. 11, 2014 | 15:29PM EST
  29. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 11, 2014 | 08:05AM EST
  30. Stocks Hitting 52-Week Highs

    Benzinga | Aug. 8, 2014 | 10:21AM EST
  31. Benzinga's Top Initiations

    Benzinga | Aug. 8, 2014 | 09:15AM EST
  32. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga | Aug. 8, 2014 | 08:38AM EST
  33. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst Pharmaceuticals

    Benzinga | Aug. 7, 2014 | 09:36AM EST
  34. Ebola Stocks Continue Higher

    Benzinga | Aug. 4, 2014 | 14:14PM EST
  35. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga | Jun. 23, 2014 | 13:34PM EST
  36. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst Pharmaceuticals on Positive Expectations for Oral HAE Drug

    Benzinga | Mar. 10, 2014 | 09:11AM EST
  37. Benzinga's Top Initiations

    Benzinga | Mar. 10, 2014 | 08:41AM EST
  38. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, XOMA, BCRX Moving Higher, RP, ODP, VVUS, AINV, MGIC, ALSN Lower

    Benzinga | Feb. 25, 2014 | 09:41AM EST
  39. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 25, 2014 | 08:08AM EST
  40. Benzinga's Top Downgrades

    Benzinga | Jan. 27, 2014 | 08:03AM EST
  41. Benzinga's Top Initiations

    Benzinga | Jan. 21, 2014 | 09:53AM EST
  42. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under Review, Awaiting Details

    Benzinga | Jan. 13, 2014 | 10:32AM EST
  43. US Stock Futures Gain Ahead Of GDP Data

    Benzinga | Dec. 20, 2013 | 07:11AM EST
  44. BioCryst Files Peramivir NDA for Influenza

    Benzinga | Dec. 20, 2013 | 06:31AM EST
  45. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 18, 2013 | 08:36AM EST
  46. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary Angioedema into Preclinical Development

    Benzinga | Dec. 18, 2013 | 07:09AM EST
  47. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients with Hereditary Angioedema

    Benzinga | Nov. 7, 2013 | 11:53AM EST
  48. Benzinga's Top Pre-Market Gainers

    Benzinga | Sep. 17, 2013 | 08:11AM EST
  49. BioCryst Awarded Up to $22M Contract by the NIAID to Develop BCX4430 for the Treatment of Marburg Virus Disease

    Benzinga | Sep. 17, 2013 | 07:06AM EST
  50. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' Believes ViroPharma, Shire Could Be Interested

    Benzinga | Aug. 28, 2013 | 14:43PM EST
Trading Center